We are seeking to sublicense our technology for further development and commercialization of products we have developed and validated using grant funding from the National Cancer Institute. The Agkura® Personal Score blood test is furthest along in development and has been offered under CLIA regulations in the US and in India. All our imaging and therapeutic products are in pre-clinical stages of development.

Please use the “Contact Us” button to send us a message. We look forward to speaking with you.